AI Article Synopsis

  • The study investigates metabolic changes related to solitary pulmonary nodules (SPNs) using plasma samples to identify potential diagnostic markers.
  • It analyzed 1160 plasma samples from healthy individuals and patients with benign or malignant SPNs using advanced mass spectrometry techniques.
  • Results showed distinct metabolic profiles between healthy individuals and SPN patients, but no significant differences existed between benign and malignant SPNs, indicating early metabolic changes but limited differentiation in later stages.

Article Abstract

Introduction: Solitary pulmonary nodules (SPNs) are commonly found in imaging technologies, but are plagued by high false-positive rates.

Objective: We aimed to identify metabolic alterations in SPN etiology and diagnosis using less invasive plasma metabolomics and lipidomics.

Methods: In total, 1160 plasma samples were obtained from healthy volunteers (n = 280), benign SPNs (n = 157) and malignant SPNs (stage I, n = 723) patients enrolled from 5 independent centers. Gas chromatography-triple quadrupole mass spectrometry (GC‒MS) and liquid chromatography-Q Exactive Hybrid Quadrupole-Orbitrap mass spectrometry (LC‒MS) were used to analyze the samples for untargeted metabolomics and lipidomics.

Results And Conclusion: GC‒MS-based metabolomics revealed 1336 metabolic features, while LC‒MS-based lipidomics revealed 6088 and 2542 lipid features in the positive and negative ion modes, respectively. The metabolic and lipidic characteristics of healthy vs. benign or malignant SPNs exhibited substantial pattern differences. Of note, benign and malignant SPNs had no significant variations in circulating metabolic and lipidic markers and were validated in four other centers. This study demonstrates evidence of early metabolic alterations that can possibly distinguish SPNs from healthy controls, but not between benign and malignant SPNs.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11306-022-01929-0DOI Listing

Publication Analysis

Top Keywords

benign malignant
16
malignant spns
16
plasma metabolomics
8
solitary pulmonary
8
pulmonary nodules
8
metabolic alterations
8
mass spectrometry
8
metabolic lipidic
8
spns
7
benign
5

Similar Publications

Robotic bronchoscopy: Evolution of advanced diagnostic technologies for pulmonary lesions.

Best Pract Res Clin Anaesthesiol

March 2024

1400 Holcombe Blvd, FC 13.2000, Houston, TX, 77030, USA. Electronic address:

Lung cancer is among one of the most commonly diagnosed malignancies and is the leading cause of cancer-related mortality in both men and women globally, with an estimated 1.8 million deaths annually. Moreover, it is also the leading cause of cancer related deaths in the United States (U.

View Article and Find Full Text PDF

Phyllodes tumor is a type of fibroepithelial neoplasm involving the breast. This tumor is rarely reported in adolescents and the elderly and has a peak incidence in middle-aged women. Histologically, phyllodes tumors are classified as benign, borderline, or malignant.

View Article and Find Full Text PDF

Objective: This study aimed to assess the degree of effect of central lymph node dissection on postoperative hypoparathyroidism incidence.

Methods: The incidence of postoperative hypoparathyroidism was compared between patients receiving thyroidectomy with central neck dissection for papillary thyroid carcinoma and those undergoing thyroidectomy for benign thyroid diseases (thyroid follicular adenoma and/or nodular goiter) necessitating surgical intervention.

Results: The incidence of postoperative hypoparathyroidism was not significantly different between the groups of lobe thyroidectomy for benign thyroid diseases and lobe thyroidectomy with ipsilateral central lymph node dissection for papillary thyroid carcinoma (immediate: 9.

View Article and Find Full Text PDF

Prostate cancer (PC) progresses from benign epithelium through pre-malignant lesions, localized tumors, metastatic dissemination, and castration-resistant stages, with some cases exhibiting phenotype plasticity under therapeutic pressure. However, high-resolution insights into how cell phenotypes evolve across successive stages of PC remain limited. Here, we present the Prostate Cancer Cell Atlas (PCCAT) by integrating ∼710,000 single cells from 197 human samples covering a spectrum of tumor stages.

View Article and Find Full Text PDF

An optimized support vector machine for lung cancer classification system.

Front Oncol

December 2024

Honorary Research Associate, Department of Operations and Quality Management, Durban University of Technology, Durban, South Africa.

Introduction: Lung cancer is one of the main causes of the rising death rate among the expanding population. For patients with lung cancer to have a higher chance of survival and fewer deaths, early categorization is essential. The goal of thisresearch is to enhance machine learning to increase the precision and quality of lung cancer classification.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!